| Product Code: ETC9937571 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Alzheimer's Disease Diagnostic Market - Industry Life Cycle |
3.4 United Kingdom (UK) Alzheimer's Disease Diagnostic Market - Porter's Five Forces |
3.5 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Alzheimer's disease in the UK |
4.2.2 Growing aging population in the UK |
4.2.3 Advancements in diagnostic technologies for Alzheimer's disease |
4.3 Market Restraints |
4.3.1 High cost associated with Alzheimer's disease diagnostics |
4.3.2 Limited reimbursement policies for diagnostic tests |
4.3.3 Lack of awareness and education about early diagnosis of Alzheimer's disease |
5 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Trends |
6 United Kingdom (UK) Alzheimer's Disease Diagnostic Market, By Types |
6.1 United Kingdom (UK) Alzheimer's Disease Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Nervous System, 2021- 2031F |
6.1.4 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Examination, 2021- 2031F |
6.1.5 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.1.6 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Minor Mental State Examination, 2021- 2031F |
6.1.7 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Brain Imaging, 2021- 2031F |
6.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.3 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.4 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.5 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.6 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenues & Volume, By Academic Research Center, 2021- 2031F |
7 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Export to Major Countries |
7.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Imports from Major Countries |
8 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Key Performance Indicators |
8.1 Average age of diagnosis for Alzheimer's disease patients in the UK |
8.2 Adoption rate of new diagnostic technologies for Alzheimer's disease |
8.3 Number of research studies and clinical trials focused on Alzheimer's disease diagnostics in the UK |
9 United Kingdom (UK) Alzheimer's Disease Diagnostic Market - Opportunity Assessment |
9.1 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United Kingdom (UK) Alzheimer's Disease Diagnostic Market - Competitive Landscape |
10.1 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Alzheimer's Disease Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here